APC anti-human CD279 (PD-1) Antibody

Pricing & Availability
Clone
EH12.2H7 (See other available formats)
Regulatory Status
RUO
Other Names
PD-1
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
EH12dot2H7_APC_022508
PHA-stimulated (day-3) human peripheral blood lymphocytes were stained with CD279 (clone EH12.2H7) APC (filled histogram) or mouse IgG1, κ APC (open histogram).
  • EH12dot2H7_APC_022508
    PHA-stimulated (day-3) human peripheral blood lymphocytes were stained with CD279 (clone EH12.2H7) APC (filled histogram) or mouse IgG1, κ APC (open histogram).
  • EH12dot2H7_APC_072209.jpg
    Human peripheral blood lymphocytes were stained with CD279 (clone EH12.2H7) APC and CD3 (clone UCHT1) PerCP/Cy5.5.
See APC spectral data
Cat # Size Price Quantity Avail. Save
329907 25 tests 100,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
329908 100 tests 212,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Programmed cell death 1 (PD-1), also known as CD279, is a 55 kD member of the immunoglobulin superfamily. CD279 contains the immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic region and plays a key role in peripheral tolerance and autoimmune disease. CD279 is expressed predominantly on activated T cells, B cells, and myeloid cells. PD-L1 (B7-H1) and PD-L2 (B7-DC) are ligands of CD279 (PD-1) and are members of the B7 gene family. Evidence suggests overlapping functions for these two PD-1 ligands and their constitutive expression on some normal tissues and upregulation on activated antigen-presenting cells. Interaction of CD279 ligands results in inhibition of T cell proliferation and cytokine secretion.

Product Details
Technical data sheet

Product Details

Reactivity
Human, African Green, Baboon, Chimpanzee, Common Marmoset, Cynomolgus, Rhesus, Squirrel Monkey
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (please contact technical support for concentration and total µg amount, or use our Lookup tool if you have a lot number.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of ligand binding1-3 and immunohistochemical staining of paraformaldehyde fixed frozen sections13. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 329911 and 329912). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 329926) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Dorfman DM, et al. 2006 Am. J. Surg. Pathol. 30:802. (FA)
  2. Radziewicz H, et al. 2007. J. Virol. 81:2545. (FA)
  3. Velu V, et al. 2007. J. Virol. 81:5819. (FA)
  4. Zahn RC, et al. 2008. J. Virol. 82:11577. PubMed
  5. Chang WS, et al. 2008. J. Immunol. 181:6707. (FC) PubMed
  6. Nakamoto N, et al. 2009. PLoS Pathog. 5:e1000313. (FA)
  7. Jones RB, et al. 2009. J. Virol. 83:8722. (FC) PubMed
  8. Vojnov L, et al. 2010. J. Virol. 84:753. (FC) PubMed
  9. Radziewicz H, et al. 2010. J. Immunol. 184:2410. (FC) PubMed
  10. Monteriro P, et al. 2011. J. Immunol. 186:4618. PubMed
  11. Conrad J, et al. 2011. J. Immunol. 186:6871. PubMed
  12. Salisch NC, et al. 2010. J. Immunol. 184:476. (Rhesus reactivity)
  13. Li H and Pauza CD. 2015. Eur. J. Immunol. 45:298. (IHC)
  14. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Xu H, et al. 2013. J Leukoc Biol. 93:943. PubMed
  2. Tian X, et al. 2015. J Immunol. 194:3873. PubMed
  3. Blackburn M, et al. 2015. J Immunol. 195: 3227 - 3236. PubMed
  4. Miles B, et al. 2015. Nat Commun. 6: 8608. PubMed
  5. Javed A, et al. 2015. PLoS One. 10: 0142086. PubMed
  6. Chew G, et al. 2016. PLoS Pathog. 12: 1005349. PubMed
  7. Beyer M, et al. 2016. Nat Immunol. 17:593-603. PubMed
  8. Miles B, et al. 2016. PLoS Pathog. 12:e1005924. PubMed
  9. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  10. Wang D, et al. 2017. Leukemia. 10.1038/leu.2017.69. PubMed
  11. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  12. Rodda LB, et al. 2020. Cell. 184(1):169-183.e17. PubMed
  13. Wang S, et al. 2021. Exp Ther Med. 21:37. PubMed
  14. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  15. Tan EE, et al. 2020. J Clin Invest. 130:5817. PubMed
  16. Cai J, et al. 2021. eLife. 10:00. PubMed
  17. Todorova D, et al. 2020. EBioMedicine. 62:103120. PubMed
  18. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  19. Lecciso M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01918. PubMed
  20. Wang Z, et al. 2018. Nat Commun. 9:824. PubMed
  21. Niu C, et al. 2018. Front Immunol. 9:1759. PubMed
  22. Frasca D, et al. 2018. PLoS One. 13:e0197472. PubMed
  23. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  24. Zhao Y et al. 2018. Cell reports. 24(2):379-390 . PubMed
  25. Kraig E, et al. 2018. Exp Gerontol. 105:53. PubMed
  26. Wei J, et al. 2019. J Immunother Cancer. 7:209. PubMed
  27. Zou F, et al. 2019. Nat Commun. 10:4109. PubMed
  28. Martín–Gayo E, et al. 2020. Cell Rep. 30:984. PubMed
  29. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  30. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  31. Schultheiß C, et al. 2020. Immunity. 53(2):442-455.e4.. PubMed
RRID
AB_940473 (BioLegend Cat. No. 329907)
AB_940475 (BioLegend Cat. No. 329908)

Antigen Details

Structure
Immunoglobulin superfamily
Distribution

Transiently expressed on CD4- CD8- thymocytes; upregulated in thymocytes and splenic T and B lymphocytes; expressed on activated myeloid cells

Ligand/Receptor
B7-H1 (also known as PD-L1) and B7-DC (PD-L2)
Cell Type
B cells, Lymphocytes, T cells, Thymocytes, Tregs
Biology Area
Cancer Biomarkers, Immunology, Inhibitory Molecules
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Gene ID
5133 View all products for this Gene ID
UniProt
View information about CD279 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD279 Reagents
Description Clone Applications
Purified anti-human CD279 (PD-1) EH12.2H7 FC, Block, IHC-F
FITC anti-human CD279 (PD-1) EH12.2H7 FC
PE anti-human CD279 (PD-1) EH12.2H7 FC
Alexa Fluor® 647 anti-human CD279 (PD-1) EH12.2H7 FC
Brilliant Violet 785™ anti-human CD279 (PD-1) EH12.2H7 FC
PE/Dazzle™ 594 anti-human CD279 (PD-1) EH12.2H7 FC
Alexa Fluor® 488 anti-human CD279 (PD-1) EH12.2H7 FC
PerCP anti-human CD279 (PD-1) EH12.2H7 FC
TotalSeq™-D0088 anti-human CD279 (PD-1) EH12.2H7 PG
Brilliant Violet 711™ anti-human CD279 (PD-1) EH12.2H7 FC
Brilliant Violet 650™ anti-human CD279 (PD-1) EH12.2H7 FC
Alexa Fluor® 700 anti-human CD279 (PD-1) EH12.2H7 FC
Brilliant Violet 421™ anti-human CD279 (PD-1) EH12.2H7 FC
Purified anti-human CD279 (PD-1) (Maxpar® Ready) EH12.2H7 FC, CyTOF®
APC/Fire™ 750 anti-human CD279 (PD-1) EH12.2H7 FC
TotalSeq™-A0088 anti-human CD279 (PD-1) EH12.2H7 PG
PerCP/Cyanine5.5 anti-human CD279 (PD-1) EH12.2H7 FC
Brilliant Violet 605™ anti-human CD279 (PD-1) EH12.2H7 FC
GoInVivo™ Purified anti-human CD279 (PD-1) EH12.2H7 FC, Block, IHC
PE/Fire™ 640 anti-human CD279 (PD-1) EH12.2H7 FC
Biotin anti-human CD279 (PD-1) EH12.2H7 FC
TotalSeq™-B0088 anti-human CD279 (PD-1) EH12.2H7 PG
TotalSeq™-C0088 anti-human CD279 (PD-1) EH12.2H7 PG
APC/Cyanine7 anti-human CD279 (PD-1) EH12.2H7 FC
Ultra-LEAF™ Purified anti-human CD279 (PD-1) EH12.2H7 FC, Block, IHC-F
Brilliant Violet 750™ anti-human CD279 (PD-1) EH12.2H7 FC
Brilliant Violet 510™ anti-human CD279 (PD-1) EH12.2H7 FC
Pacific Blue™ anti-human CD279 (PD-1) EH12.2H7 FC
PE/Cyanine7 anti-human CD279 (PD-1) EH12.2H7 FC
Go To Top Version: 2    Revision Date: 01.22.2015

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Purified anti-human CD279 (PD-1)

  • FITC anti-human CD279 (PD-1)

  • PE anti-human CD279 (PD-1)

  • Alexa Fluor® 647 anti-human CD279 (PD-1)

  • Brilliant Violet 785™ anti-human CD279 (PD-1)

  • PE/Dazzle™ 594 anti-human CD279 (PD-1)

  • Alexa Fluor® 488 anti-human CD279 (PD-1)

  • PerCP anti-human CD279 (PD-1)

  • TotalSeq™-D0088 anti-human CD279 (PD-1)

  • Brilliant Violet 711™ anti-human CD279 (PD-1)

  • Brilliant Violet 650™ anti-human CD279 (PD-1)

  • Alexa Fluor® 700 anti-human CD279 (PD-1)

  • Brilliant Violet 421™ anti-human CD279 (PD-1)

  • Purified anti-human CD279 (PD-1) (Maxpar® Ready)

  • APC/Fire™ 750 anti-human CD279 (PD-1)

  • TotalSeq™-A0088 anti-human CD279 (PD-1)

  • PerCP/Cyanine5.5 anti-human CD279 (PD-1)

  • Brilliant Violet 605™ anti-human CD279 (PD-1)

  • GoInVivo™ Purified anti-human CD279 (PD-1)

  • PE/Fire™ 640 anti-human CD279 (PD-1)

  • Biotin anti-human CD279 (PD-1)

  • TotalSeq™-B0088 anti-human CD279 (PD-1)

  • TotalSeq™-C0088 anti-human CD279 (PD-1)

  • APC/Cyanine7 anti-human CD279 (PD-1)

  • Ultra-LEAF™ Purified anti-human CD279 (PD-1)

  • Brilliant Violet 750™ anti-human CD279 (PD-1)

  • Brilliant Violet 510™ anti-human CD279 (PD-1)

  • Pacific Blue™ anti-human CD279 (PD-1)

  • PE/Cyanine7 anti-human CD279 (PD-1)

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account